Video
The Itch Factor: Why Relief Can’t Wait in Atopic Dermatitis

Feat. Matthew Zirwas, MD, Raj Chovatiya, MD, PhD, MSCI

Podcast
Shedding New Light on Phototherapy: Now in the Comfort of Your Own Home

Feat. E. James Song, MD

CME
CMEswiper: Swipe to See CLE: Recognition and Diagnosis of Cutaneous Lupus Erythematosus: An Online Activity

With Victoria Werth, MD

Case Study
Jacked on JAKs: The Therapeutic Impact of Dose Escalation in a Case of Refractory Atopic Dermatitis

By Graham Litchman, DO, MS

Latest CMEs

Trending News

Pooled Phase 3 Data With Remibrutinib in Chronic Spontaneous Urticaria

By Authors: Sarbjit Saini, Giselle Mosnaim, Ana Giménez-Arnau, Linfeng Li, El-Djouher Martzloff, Alis Burciu, Karine Lheritier, Martin Metz

Disease Activity With Remibrutinib in Chronic Spontaneous Urticaria

By Authors: Martin Metz, Ana M. Giménez-Arnau, Petra Staubach, Marta Ferrer Puga, Kanokvalai Kulthanan, Xinghua Gao, Karine Lheritier, Christine-Elke Ortmann, Nadine Chapman-Rothe, Sibylle Haemmerle, Atsushi Fukunaga, Michihiro Hide

Botulinum Toxin Safe, Effective for Refractory Digital Ischemia

By Dermsquared Editorial Team | December 12, 2025

Long-Term Durable Responses to Cemiplimab Seen in Advanced CSCC

By Dermsquared Editorial Team | December 12, 2025

Rocatinlimab Yields Significant Improvements in Atopic Dermatitis

By Elana Gotkine (HealthDay News) | December 12, 2025

RSNA: Ultrasound Findings Can ID Cosmetic Filler-Linked Vascular Adverse Events

By Elana Gotkine (HealthDay News) | December 12, 2025

CatBoost Model Has Best Performance for Predicting Survival in Melanoma

By Dermsquared Editorial Team | December 11, 2025

Dermatoscopes Compared for Dermoscopy Performance, Teledermatology Use

By Dermsquared Editorial Team | December 11, 2025

FDA Approves Updated Label for Unloxcyt

By Lori Solomon (HealthDay News) | December 11, 2025

Slight Increase in Global Burden of Psoriasis Seen Through 2021

By Dermsquared Editorial Team | November 26, 2025